| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.31 | 0.03 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.23 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.31 | 0.04 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | 0.32 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |